156 related articles for article (PubMed ID: 38622880)
41. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
Zhang X; Li Z; Geng W; Song B; Wan C
Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
[TBL] [Abstract][Full Text] [Related]
42. Immunosuppressive therapy in aplastic anemia.
Gupta V; Kumar A; Tilak V; Saini I; Bhatia B
Indian J Pediatr; 2012 Dec; 79(12):1587-91. PubMed ID: 22274992
[TBL] [Abstract][Full Text] [Related]
43. Immunosuppressive therapies in the management of acquired immune-mediated marrow failures.
Risitano AM
Curr Opin Hematol; 2012 Jan; 19(1):3-13. PubMed ID: 22143074
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of porcine antihuman lymphocyte immunoglobulin compared to rabbit antithymocyte immunoglobulin as a first-line treatment against acquired severe aplastic anemia.
Liu L; Ding L; Hao L; Zhang X; Li X; Zhang L; Hao Z; Lei M; Zhang Y; Wu D
Ann Hematol; 2015 May; 94(5):729-37. PubMed ID: 25604721
[TBL] [Abstract][Full Text] [Related]
45. Merkel cell carcinoma developing after antithymocyte globulin and cyclosporine therapy for aplastic anemia.
Takabayashi M; Sakai R; Sakamoto H; Iemoto Y; Kanamori H; Inayama Y; Ishigatsubo Y
Anticancer Drugs; 2003 Mar; 14(3):251-3. PubMed ID: 12634621
[TBL] [Abstract][Full Text] [Related]
46. Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study.
Clé DV; Atta EH; Dias DSP; Lima CBL; Bonduel M; Sciuccati G; Medeiros LA; de Oliveira MM; Blum Fonseca PB; Saad STO; Hamerschlak N; Salvino MA; Garanito MP; Pazin-Filho A; Scheinberg P; Calado RT
Ann Hematol; 2018 Nov; 97(11):2039-2046. PubMed ID: 29978284
[TBL] [Abstract][Full Text] [Related]
47. Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia.
Scheinberg P; Townsley D; Dumitriu B; Scheinberg P; Weinstein B; Rios O; Wu CO; Young NS
Am J Hematol; 2014 May; 89(5):467-9. PubMed ID: 24415649
[TBL] [Abstract][Full Text] [Related]
48. Immunosuppressive therapy with horse anti-thymocyte globulin and cyclosporine as treatment for fulminant aplastic anemia in children.
Yagasaki H; Shichino H; Ohara A; Kobayashi R; Yabe H; Ohga S; Hamamoto K; Ohtsuka Y; Shimada H; Inoue M; Muramatsu H; Takahashi Y; Kojima S
Ann Hematol; 2014 May; 93(5):747-52. PubMed ID: 24337487
[TBL] [Abstract][Full Text] [Related]
49. Impact of antithymocyte globulin on blood cyclosporin A levels in aplastic anemia patients.
Futagi Y; Suga Y; Shimada T; Sai Y
Ann Hematol; 2023 Feb; 102(2):463-465. PubMed ID: 36435888
[No Abstract] [Full Text] [Related]
50. Increased immunosuppressive treatment combined with unrelated umbilical cord blood infusion in children with severe aplastic anemia.
Xie LN; Fang Y; Yu Z; Song NX; Kong FS; Liu XM; Zhou F
Cell Immunol; 2014; 289(1-2):150-4. PubMed ID: 24838091
[TBL] [Abstract][Full Text] [Related]
51. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.
Yoshida N; Kobayashi R; Yabe H; Kosaka Y; Yagasaki H; Watanabe K; Kudo K; Morimoto A; Ohga S; Muramatsu H; Takahashi Y; Kato K; Suzuki R; Ohara A; Kojima S
Haematologica; 2014 Dec; 99(12):1784-91. PubMed ID: 25193958
[TBL] [Abstract][Full Text] [Related]
52. Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.
Chen M; Liu C; Zhuang J; Zou N; Xu Y; Zhang W; Li J; Duan M; Zhu T; Cai H; Cao X; Wang S; Zhou D; Han B
Eur J Haematol; 2016 Mar; 96(3):291-6. PubMed ID: 25996247
[TBL] [Abstract][Full Text] [Related]
53. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
[TBL] [Abstract][Full Text] [Related]
54. Recent Advances and Long-Term Results of Medical Treatment of Acquired Aplastic Anemia: Are Patients Cured?
Scheinberg P
Hematol Oncol Clin North Am; 2018 Aug; 32(4):609-618. PubMed ID: 30047414
[TBL] [Abstract][Full Text] [Related]
55. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
[TBL] [Abstract][Full Text] [Related]
56. [Comparison of porcine antilymphocyte globulin (p-ALG) and rabbit antithymocyte globulin (r-ATG) in the treatment of children with severe aplastic anemia].
Kong LJ; He HL; Hu SY
Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):953-955. PubMed ID: 31856447
[No Abstract] [Full Text] [Related]
57. Severe aplastic anaemia--complete response to antilymphocyte globulin and cyclosporin.
Jones-Lecointe A; Murphy A; Charles W; Daisley H; Pitt-Miller P
West Indian Med J; 1999 Dec; 48(4):238-9. PubMed ID: 10639849
[TBL] [Abstract][Full Text] [Related]
58. Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.
Peffault de Latour R; Tabrizi R; Marcais A; Leblanc T; Lamy T; Mohty M; Tavitian S; Jubert C; Pasquet M; Galambrun C; Nguyen S; Cahn JY; Braun T; Deconinck E; Bay JO; Sicre de Fontbrune F; Barraco F; Socié G
Am J Hematol; 2018 May; 93(5):635-642. PubMed ID: 29377260
[TBL] [Abstract][Full Text] [Related]
59. Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.
Scheinberg P; Marte M; Nunez O; Young NS
Haematologica; 2010 Jul; 95(7):1075-80. PubMed ID: 20595102
[TBL] [Abstract][Full Text] [Related]
60. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.
Locasciulli A; Bruno B; Rambaldi A; Saracco P; Dufour C; Finelli C; Sica S; Varotto S; Arcese W; Locatelli F; Soligo D; Bacigalupo A;
Haematologica; 2004 Sep; 89(9):1054-61. PubMed ID: 15377466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
